Share
Proton pump inhibitors (PPIs) are commonly prescribed medications to help manage gastroesophageal reflux disease (GERD). In bariatric patients, especially those who have undergone procedures for weight loss, such as Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy, PPIs can help manage postoperative reflux symptoms.
However, prolonged PPI use in the bariatric population has raised concerns regarding its impact on nutrient absorption and bone health.
PPIs function by inhibiting the proton pumps in the stomach lining, thereby reducing gastric acid production. This reduction in acidity can alleviate symptoms of GERD and promote healing of the esophageal mucosa.
But we need stomach acid. It helps break down food into smaller, more absorbable components, allowing the body to extract nutrients efficiently. Without adequate acid, proteins, vitamins, and minerals cannot be adequately digested, which can lead to deficiencies over time.
Acid also acts as a natural barrier against harmful bacteria and pathogens that enter the digestive system through food, thereby reducing the risk of infection.
For bariatric patients, who already have altered digestive anatomy, maintaining healthy stomach acid levels is even more important. Medications like PPIs, while helpful for reflux, reduce acid production, which can interfere with digestion and nutrient absorption if not carefully managed.
PPI Impact on Nutrient Absorption
Gastric acid plays a vital role in the digestion and absorption of various nutrients, including calcium, magnesium, iron, and vitamin B12. The function of a PPI is to reduce gastric acidity – when acid production is reduced, the body’s ability to absorb certain vitamins and minerals can be compromised, which is especially important for bariatric patients, who are already at higher risk for nutrient deficiencies due to anatomical changes in the digestive tract. The additional impact of PPI-induced malabsorption can exacerbate these deficiencies, leading to complications such as anemia, neuropathy, and muscle weakness.
Studies have shown that long-term PPI use, even in otherwise healthy non-obese individuals, can lead to or exacerbate deficiencies in these nutrients, which are critical for overall health and well-being.1-2
One of the most well-studied effects of long-term PPI use is on calcium absorption. Calcium needs an acidic environment in the stomach to dissolve properly, allowing it to be absorbed in the small intestine. When acid is reduced, calcium absorption can decrease, which, over time, may contribute to weaker bones and a higher risk of fractures.
PPIs can also interfere with magnesium absorption, which is crucial for nerve and muscle function, heart health, and bone strength. Low levels of magnesium can lead to muscle cramps, irregular heart rhythms, or seizures. Similarly, iron absorption may be affected because stomach acid helps convert dietary iron into a form that is easier for the body to use. Reduced iron absorption can contribute to anemia, causing fatigue, weakness, and difficulty concentrating.
Vitamin B12 is another nutrient that is essential for basic bodily functions and is also impacted by PPI use. B12 in food is bound to proteins, and stomach acid is necessary to separate B12 from these proteins so it can be absorbed. Patients on prolonged PPIs may have lower B12 levels, which can lead to fatigue, neurological symptoms, or anemia if not monitored and supplemented appropriately.
PPIs don’t just affect nutrient absorption directly – they also have an impact on other substances in our body. A recent study found that people who take PPIs continuously after gastric bypass surgery are more likely to have abnormal parathyroid hormone (PTH) levels, which are necessary for keeping calcium levels stable. In fact, the study showed that the risk of having these abnormal PTH levels was more than three times higher in patients on PPIs. This finding suggests that prolonged PPI use may indirectly affect bone health by disrupting PTH regulation, adding another layer of concern for calcium and overall bone strength in bariatric patients.2
Healthcare providers may recommend lab testing, dietary adjustments, or supplementation to ensure adequate nutrient intake while continuing to manage reflux symptoms effectively.
Bone Health Concerns
Bone health is a high-priority consideration for bariatric patients. PPI use makes it even more concerning and increases the need for monitoring.
Even before factoring in medications, weight loss surgery can increase the risk of bone density loss. These procedures alter the normal digestive pathway, which can reduce the absorption of key nutrients necessary for strong bones, including calcium and vitamin D. When combined with PPI use, this risk may be amplified, making careful monitoring essential.
Osteopenia and osteoporosis, conditions characterized by reduced bone density and increased fragility, are a chief concern. Bariatric patients on PPIs may experience both direct and indirect effects that compromise bone strength. Directly, reduced stomach acid can limit calcium absorption, depriving bones of a critical building block. Indirectly, as recent research has shown, PPIs can alter parathyroid hormone (PTH) levels, which play a central role in regulating calcium balance and signaling bone remodeling. Disruptions in this delicate hormonal balance can accelerate bone loss over time.
Fracture risk is another significant concern. Studies have demonstrated that long-term PPI users have a higher likelihood of sustaining fractures, particularly in the hip, spine, and wrist. For bariatric patients, who already face the risk of reduced bone mass post-surgery, this increased risk is particularly concerning. Even minor falls or everyday activities can lead to injuries that require prolonged recovery or surgery if bone density and nutrient absorption are not tracked.
Healthcare providers often recommend proactive strategies to protect bone health. Bone mineral density (BMD) testing can help identify early signs of bone loss, while laboratory monitoring of calcium, vitamin D, and PTH levels provides a clearer picture of metabolic bone health. In some cases, providers may recommend supplements, weight-bearing exercises, or adjustments in PPI therapy to reduce potential risks.
Clinical Implications and Recommendations
Given the potential pitfalls associated with prolonged PPI use in bariatric patients, it is prudent to monitor their nutritional status and bone health regularly. Routine screening for deficiencies in calcium, magnesium, vitamin B12, and iron is highly recommended, in addition to other essential nutrients: B9, D, A, K, and E, as well as minerals such as zinc, copper, phosphate, and selenium. Additionally, bone mineral density assessments should be conducted periodically to detect early signs of osteoporosis.
In addition to using PPIs, which have their place and can be helpful, consider alternative strategies for managing reflux symptoms, such as dietary modifications, weight management, and, when appropriate, surgical interventions. The goal should be to minimize PPI use while effectively controlling reflux symptoms to reduce the risk of nutrient deficiencies and complications affecting bone health.
If you’ve had bariatric surgery and are concerned about reflux, nutrient deficiencies, or bone health, the team at Gastric Sleeve Center is here to help. Schedule a consultation today to review your labs, optimize your nutrition, and create a personalized plan to protect your long-term health.
Note: This article is based on available research and provides a general overview. Individual patient care should always be tailored to specific needs and circumstances in consultation with your healthcare provider.
1Sharma, N., Chau, W. Y., & Dobruskin, L. (2019). Effect of long-term proton pump inhibitor therapy on hemoglobin and serum iron levels after sleeve gastrectomy. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 15(10), 1682–1689. https://doi.org/10.1016/j.soard.2019.06.019.
2Carabotti, M., Annibale, B., & Lahner, E. (2021). Common Pitfalls in the Management of Patients with Micronutrient Deficiency: Keep in Mind the Stomach. Nutrients, 13(1), 208. https://doi.org/10.3390/nu13010208.
3Stevens, K., Hultin, H., & Sundbom, M. (2025). Continuous PPI Treatment After Gastric Bypass Increases the Risk of Pathological PTH Levels at 10 Years Postoperatively. Obesity surgery, 35(3), 941–945. https://doi.org/10.1007/s11695-025-07692-0.
